Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid

EU orphan designation number: EU/3/07/497
Active ingredient: 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid
Indication: Treatment of hepatocellular carcinoma
Sponsor: Quintiles Ireland Ltd
East Point Business Park, Fairview, Dublin 3, Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/10/2007 Centralised Orphan - Designation EMEA/OD/046/07 (2007)5246 of 22/10/2007
07/03/2011 Centralised Orphan - Removal of orphan designation from Community Register